Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL

Nature Medicine

Volumn 7, Issue 6, 2001, Pages 680-686

  Altucci, Lucia ^a,b   Rossin, Aurelie ^a   Raffelsberger, Wolfgang ^a   Reitmair, Armin ^a   Chomienne, Christine ^c   Gronemeyer, Hinrich ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOREGULATION; CANCER CELL; CANCER CHEMOTHERAPY; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034961181     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/89050     Document Type: Article

References (44)

1. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?
2. Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment
3. 13-cis-retinoic acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix
4. 13-cis-retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin
5. Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid
6. Differentiation therapy for acute promyelocytic leukemia
7. The molecular biology of acute promyelocytic leukemia
8. Retinoid receptors in health and disease: Co-regulators and the chromatin connection
9. Retinoids in cancer chemoprevention
10. Recent advances in chemoprevention of cancer
11. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
12. Two distinct actions of retinoid-receptor ligands
13. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists
14. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation
15. Human A1, a Bcl-2-related gene, is induced in leukemic cells by cytokines as well as differentiating factors
16. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression
17. IAP family proteins - Suppressors of apoptosis
18. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
19. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
20. Apoptosis control by death and decoy receptors
21. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
22. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity
23. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
24. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
25. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
26. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II
27. The receptor for the cytotoxic ligand TRAIL
28. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines
29. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L- induced apoptosis of human acute leukemia cells
30. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells
31. Programmed cell death and the control of cell survival: Lessons from the nervous system
32. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNF-α-induced apoptosis
33. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
34. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
35. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein
36. Signal transduction. A cellular rescue team
37. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases
38. Dual mechanisms of action of the retinoid CD437: Nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squarnous cell carcinoma cells
39. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
40. Safety and antitumor activity of recombinant soluble Apo2 ligand
41. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis
42. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship